BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27738819)

  • 1. Paclitaxel-Coated Balloons for the Treatment of Dysfunctional Dialysis Access. Results from a Single-Center, Retrospective Analysis.
    Kitrou PM; Spiliopoulos S; Papadimatos P; Christeas N; Petsas T; Katsanos K; Karnabatidis D
    Cardiovasc Intervent Radiol; 2017 Jan; 40(1):50-54. PubMed ID: 27738819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicenter Global Registry of Paclitaxel Drug-Coated Balloon in Dysfunctional Arteriovenous Fistulae and Grafts: 6-Month Results.
    Karnabatidis D; Kitrou PM; Ponce P; Chong TT; Pietura R; Pegis JD; Ko PJ; Lin CH;
    J Vasc Interv Radiol; 2021 Mar; 32(3):360-368.e2. PubMed ID: 33495064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial.
    Katsanos K; Karnabatidis D; Kitrou P; Spiliopoulos S; Christeas N; Siablis D
    J Endovasc Ther; 2012 Apr; 19(2):263-72. PubMed ID: 22545894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel-Coated Balloons for the Treatment of Symptomatic Central Venous Stenosis in Dialysis Access: Results from a Randomized Controlled Trial.
    Kitrou PM; Papadimatos P; Spiliopoulos S; Katsanos K; Christeas N; Brountzos E; Karnabatidis D
    J Vasc Interv Radiol; 2017 Jun; 28(6):811-817. PubMed ID: 28434662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of Paclitaxel Drug-Eluting Balloon Angioplasty Versus Standard Balloon Angioplasty in Stenosis of Native Hemodialysis Arteriovenous Fistulas: An Analysis of Clinical Success, Primary Patency and Risk Factors for Recurrent Dysfunction.
    Yildiz I
    Cardiovasc Intervent Radiol; 2019 May; 42(5):685-692. PubMed ID: 30719539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis.
    Trerotola SO; Saad TF; Roy-Chaudhury P;
    J Vasc Interv Radiol; 2020 Jan; 31(1):1-14.e5. PubMed ID: 31706886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real-world experience and longitudinal follow up.
    Phang CC; Tan RY; Pang SC; Tan CW; Teh SP; Cheng RW; Kho YX; Chong TT; Gogna A; Foo WY; Tan CS
    Nephrology (Carlton); 2019 Dec; 24(12):1290-1295. PubMed ID: 30901497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranger™ paclitaxel-coated balloon versus conventional balloon angioplasty for treatment of failing arteriovenous fistulas and grafts in haemodialysis patients: A retrospective cohort study.
    Soon SX; Tan RY; Pang SC; Yap CJ; Patel A; Gogna A; Tan CS; Chong TT; Tang TY
    J Vasc Access; 2023 Sep; 24(5):1032-1041. PubMed ID: 34965773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plain versus paclitaxel-coated balloon angioplasty in arteriovenous fistula and graft stenosis: An umbrella review.
    Lazarides MK; Christaina E; Antoniou GA; Argyriou C; Trypsianis G; Georgiadis GS
    J Vasc Access; 2022 Nov; 23(6):981-988. PubMed ID: 34058909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-Coated Balloon versus Plain Balloon Angioplasty for Dysfunctional Autogenous Radiocephalic Arteriovenous Fistulas: A Prospective Randomized Controlled Trial.
    Kim JW; Kim JH; Byun SS; Kang JM; Shin JH
    Korean J Radiol; 2020 Nov; 21(11):1239-1247. PubMed ID: 32729275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial.
    Kitrou PM; Spiliopoulos S; Katsanos K; Papachristou E; Siablis D; Karnabatidis D
    J Vasc Interv Radiol; 2015 Mar; 26(3):348-54. PubMed ID: 25542635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Coated Balloons for Dysfunctional Haemodialysis Venous Access: A Patient Level Meta-Analysis of Randomised Controlled Trials.
    Fong KY; Zhao JJ; Tan E; Syn NL; Sultana R; Zhuang KD; Chua JME; Patel A; Irani FG; Tay KH; Tan BS; Too CW
    Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):610-621. PubMed ID: 34362627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Paclitaxel Balloon for Hemodialysis Stenosis Fistulae After One Year Compared to High-Pressure Balloons: A Controlled, Multicenter, Randomized Trial.
    Moreno-Sánchez T; Moreno-Ramírez M; Machancoses FH; Pardo-Moreno P; Navarro-Vergara PF; García-Revillo J
    Cardiovasc Intervent Radiol; 2020 Mar; 43(3):382-390. PubMed ID: 31722055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.
    Flu H; Breslau PJ; Krol-van Straaten JM; Hamming JF; Lardenoye JW
    J Vasc Surg; 2008 Sep; 48(3):659-68. PubMed ID: 18572358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel coated balloon versus conventional balloon angioplasty in dysfunctional dialysis arteriovenous fistula: a systematic review and meta-analysis of randomized controlled trials.
    Luo C; Liang M; Liu Y; Zheng D; He Q; Jin J
    Ren Fail; 2022 Dec; 44(1):155-170. PubMed ID: 35166168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Hemodialysis Vascular Access Repeated Stenosis with Paclitaxel-Coated Balloon Angioplasty: A Retrospective Study.
    Chen C; Gao J; Gong F; Liu L; Shi P; Ma S
    Blood Purif; 2024; 53(6):486-492. PubMed ID: 38198755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-coated balloons versus conventional percutaneous transluminal angioplasty for treatment-naïve dysfunctional arteriovenous fistulas.: A 10-year single center retrospective study.
    AlQubaisi A; Arabi M; AlZahrani Y; Bashir O
    Saudi Med J; 2024 Jul; 45(7):741-744. PubMed ID: 38955442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent Stenoses in Arteriovenous Fistula (AVF) for Dialysis Access: cuttIng ballooN angioplaSTy combined wITh paclitaxel drUg-coaTed balloon angioplasty, an observatIONal study (INSTITUTION Study).
    Tan Z; Chan SXJM; Da Zhuang K; Urlings T; Leong S; Chua JME; Patel A; Irani FG; Chandramohan S; Tay KH; Damodharan K; Lo RHG; Venkatanarasimha N; Too CW; Tan BS; Tan CS; Chong TT; Win HH; Rahman ASBA; Sulaiman MSB; Gogna A
    Cardiovasc Intervent Radiol; 2022 May; 45(5):646-653. PubMed ID: 35059796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel-Coated Balloons Compared to Plain Balloon Angioplasty in the Management of Dysfunctional Arteriovenous Fistulae: A Single-Center Randomized Clinical Trial.
    Arabi M; Salman R; Alharbi A; Alzahrani Y; Bashir O; Qazi S; Abdallah M; Farooqui M; Hejaili F; Almoaiqel M
    Saudi J Kidney Dis Transpl; 2021; 32(1):118-127. PubMed ID: 34145121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel drug-eluting balloons to recurrent in-stent stenoses in autogenous dialysis fistulas: a retrospective study.
    Swinnen JJ; Zahid A; Burgess DC
    J Vasc Access; 2015; 16(5):388-93. PubMed ID: 26044898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.